2,480
Views
26
CrossRef citations to date
0
Altmetric
Special Review Series

Managing ITP and thrombocytopenia in pregnancy

&
Pages 300-306 | Received 01 Feb 2019, Accepted 29 Jun 2019, Published online: 11 Jul 2019

References

  • Reese JA, Deschamps DR, McIntosh JJ, Knudtson EJ, Peck JD, Vesely SK, George JN. Platelet counts throughout uncomplicated pregnancies. Blood 2015;126:2256.
  • Myers B. Diagnosis and management of maternal thrombocytopenia in pregnancy. Br J Haematol 2012;158:3–15. doi: 10.1111/j.1365-2141.2012.09135.x.
  • Sainio S, Kekomaki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 2000;79:744–749.
  • Nisha S, Amita D, Uma S, Tripathi AK, Pushplata S. Prevalence and characterization of thrombocytopenia in pregnancy in Indian women.Indian J Hematol Blood Transfus 2012;28(2):77–81. doi: 10.1007/s12288-011-0107-x.
  • Danaee A, Robinson S, Okoli S, Kyle P, Costa Vieira M, Pasupathy D. Incidence and aetiology of thrombocytopenia in twin pregnancies in a tertiary referral centre. Blood 2014;124:4188.
  • Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Khudtson EJ, Terrell DR, Vesely SK, George JN. Platelet counts during pregnancy. N Engl J Med 2018;379:32–43. doi: 10.1056/NEJMoa1802897.
  • Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries.Am J Obstet Gynecol 1990;162(3):731–734. doi: 10.1016/0002-9378(90)90996-k.
  • Vishwekar PS, Yadav RK, Gohel CB. Thrombocytopenia during pregnancy and its outcome – a prospective study. J Krishna Inst Medical Sciences Univ 2017;6:82–89.
  • American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol 2019;133: e1-e25. doi: 10.1097/AOG.0000000000003019.
  • Lowe SA, Bowyer L, Lust K, McMahon LP, Morton MR, North RA, Paech MJ, Said JM. SOMANZ guidelines for the management of hypertensive disorders of pregnancy. Aust N Z J Obstet Gynaecol 2015;55:e1–29. doi: 10.1111/ajo.12399.
  • Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome).Am J Obstet Gynecol 1993;169(4):1000–1006. doi: 10.1016/0002-9378(93)90043-i.
  • Axe K, Ch’ng C. Acute fatty liver of pregnancy: a review of 20 cases. Gut 2012;61:A200–201. doi: 10.1136/gutjnl-2012-302514c.41.
  • Knight M, Nelson-Piercy C, Kurinczuk JJ, Spark P, Brocklehurst P. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008;57:951–956. doi: 10.1136/gut.2008.148676.
  • Mellouli MM, Amara FB, Mahrebi H, Bouchnack M, Khaled N, Reziga H. Acute fatty liver of pregnancy over a 10-year period at a Tunisian tertiary care center.Int J Gynecol Obstet 2012;117(1):88–89. doi: 10.1016/j.ijgo.2011.11.012.
  • Rajasekhar A, Gernsheimer T, Stasi R, James AH. 2013 Clinical practice guide on thrombocytopenia in pregnancy. Washington, DC: American Society of Hematology;2013 cited 2019 Jan 31. Available from. http://www.hematology.org/Clinicians/Guidelines-Quality/Quick-Reference.aspx.
  • Cines DB, Blanchette VS, Chir B. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995–1008. doi: 10.1056/NEJMra010501.
  • Care A, Pavord S, Knight M, Alfirevic Z. Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study. Br J Obstet Gynaecol 2018;125:604–612. doi: 10.1111/1471-0528.14697.
  • Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 2003;102:4306–4311. doi: 10.1182/blood-2002-10-3317.
  • Fogerty AE. Thrombocytopenia in pregnancy: mechanisms and management. Transfus Med Rev 2018;32:225–229. doi: 10.1016/j.tmrv.2018.08.004.
  • Haliloglu B, Benli AF, Celik A, Ilter E, Coksuer H, Ozekici U. Negative correlation between D-dimer and homocysteine levels during pregnancy and the postpartum period: a prospective study. Eur J Obstet Gynecol Reprod Biol 2010;153:23–26. doi: 10.1016/j.ejogrb.2010.06.018.
  • Gilmore KS, McLintock C. Maternal and fetal outcomes of primary immune thrombocytopenia during pregnancy: A retrospective study. Obstet Med 2018;11:12–16. doi: 10.1177/1753495X17727408.
  • Yuce T, Acar D, Kalafat E, Alkilic A, Cetindag E, Soylemez F. Thrombocytopenia in pregnancy: do the time of diagnosis and delivery route affect pregnancy outcome in parturients with idiopathic thrombocytopenic purpura?. Int J Hematol 2014;100:540–544.
  • Kawaguchi K, Matsubara K, Takafuta T, Shinzato I, Tanaka Y, Iwata A, Nigami H, Takeuchi Y, Fukaya T. Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia. Int J Hematol 2014;99:570–576. doi: 10.1007/s12185-014-1562-6.
  • Aiyelaagbe S, Hobson M, Byrd LM, Tower CL. Outcomes in women with thrombocytopenia in pregnancy. Arch Dis Child Fetal Neonatal Ed 2014;99:A1–180. doi: 10.1136/archdischild-2014-306576.1.
  • Rottenstreich A, Israeli N, Levin G, Rottenstreich M, Elchalal U, Kalish Y. Clinical characteristics, neonatal risk and recurrence rate of gestational thrombocytopenia with platelet count . Eur J Obstet Gynecol Reprod Biol 2018;231:75–79. doi: 10.1016/j.ejogrb.2018.10.026.
  • Loustau V, Debouverie O, Canoui-Poitrine F, Baili L, Khellaf M, Touboul C, Languille L, Loustau M, Bierling P, Haddad B, et al. Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women. Br J Haematol 2014;166:929–935. doi: 10.1111/bjh.12976.
  • Belkin A, Levy A, Sheiner E. Perinatal outcomes and complications of pregnancy in women with immune thrombocytopenic purpura. J Matern Fetal Neonatal Med 2009;22:1081–1085. doi: 10.3109/14767050903029592.
  • Sun D, Shehata N, Xiang YY, Gregorovich S, De France B, Arnold DM, Shah PS, Malinowski AK. Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy. Blood 2016;128:1329–1335. doi: 10.1182/blood-2016-04-710285.
  • Wang X, Xu Y, Luo W, Feng H, Luo Y, Wang Y, Liao H. Thrombocytopenia in pregnancy with different diagnoses.Med 2017;96(29):e7561. doi: 10.1097/MD.0000000000007561.
  • Neunert CE, Cooper N. Evidence-based management of immune thrombocytopenia: ASH guideline update. Hematology Am Soc Hematol Educ Program 2018;568–575. doi: 10.1182/asheducation-2018.1.568.
  • RACP: The Haematology Society of Australia and New Zealand top 5 Evolve low-value practices and interventions. Sydney, NSW: RACP, 2015 September [cited 2019 Jan 30]; Available from: https://evolve.edu.au/published-lists/hsanz/
  • Skipper MS, Rubak P, Stentoft J, Hvas AM, Larsen OH. Evaluation of platelet function in thrombocytopenia. Platelets 2018;29:270–276. doi: 10.1080/09537104.2017.1296566.
  • Kam PCA, Thompson SA, Liew ACS. Thrombocytopenia in the parturient. Anaesthesia 2004;59:255–264. doi: 10.1111/j.1365-2044.2004.03576.x.
  • Ozelo MC, Colella MP, de Paula EV, Virgilio Do Nascimento ACK, Villaca PR, Bernardo WM. Guideline on immune thrombocytopenia in adults: associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: associação Médica Braslieira. Hematol Transfus Cell Ther 2018;40:50–74. doi: 10.1016/j.htct.2017.11.001.
  • British Committee for Standards in Haematology. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2013;120:574–596.
  • Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital abnormalities. Am J Med Genet 1999;86:242–244.
  • Wei Y, Ji XB, Wang YW, Wang JX, Yang EQ, Wang ZC, Sang YQ, Bi ZM, Ren CA, Zhou F, et al. High-dose dexamethasone versus prednisone for the treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood 2016;127:296–302. doi: 10.1182/blood-2015-07-659656.
  • Kadir RA, McLintock C. Thrombocytopenia and disorders of platelet function in pregnancy. Semin Thromb Hemost 2011;37:640–652. doi: 10.1055/s-0031-1291374.
  • Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood 2013;121:38–47. doi: 10.1182/blood-2012-08-448944.
  • Practice Bulletin ACOG. No 207: thrombocytopenia in pregnancy. Obstet Gynecol 2019;133:e181–193. doi: 10.1097/AOG.0000000000003100.
  • Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168–186. doi: 10.1182/blood-2009-12-255992.
  • Gall B, Yee A, Berry B, Bircham D, Hayashi A, Dansereau J, Hart J. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura. J Obstet Gynaecol Can 2010;32:1167–1171.
  • Klink DT, van Elburg RM, Schreurs MW, van Well GT. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol 2008;2008:271–363. doi: 10.1155/2008/271363.
  • Chakravaty E, Murray E, Kelman A, Farmer P. Pregnancy outcomes in patients with autoimmune diseases treated with rituximab. Blood 2011;117:1499–1506. doi: 10.1182/blood-2010-07-295444.
  • Das G, Damotte V, Gelfand J, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R. Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm 2018;5:e453. doi: 10.1212/NXI.0000000000000453.
  • Pavanello F, Zucca E, Ghielmini M. Rituximab: 13 open questions after 20 years of clinical use. Cancer Treat Rev 2017;53:38–46. doi: 10.1016/j.ctrv.2016.11.015.
  • Schmid J, Piroth D, Buhrlen M, Maass N, Brummendorf TH, Galm O. Successful rituximab treatment of refractory immune thrombocytopenia during pregnancy. Onkologie 2011;34:240.
  • Burnette BL, Jentoft MA, Porrata LF, Boyce TG, Witzig TE. Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management. J Clin Oncol 2014;32:e14–17. doi: 10.1200/JCO.2012.47.6994.
  • Anglin BV, Rutherford C, Ramus R, Lieser M, Jones DB. Immune thrombocytopenic purpura during pregnancy: laparoscopic treatment. JSLS J Soc Laparoend 2001;5:63–67.
  • Griffiths J, Sia W, Shapiro AM, Tataryn I, Turner AR. Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy. J Obstet Gynaecol Can 2005;27:771–774.
  • Gottlieb P, Axelsson O, Bakos O, Rastad J. Splenectomy during pregnancy: an option in the treatment of autoimmune thrombocytopenic purpura. B J Obstet Gynaecol 1999;106:373–375. doi: 10.1111/j.1471-0528.1999.tb08278.x.
  • Mahey R, Kaur SD, Chumber S, Kriplani A, Bhatla N. Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura. BMJ Case Rep 2013. Published online: 19 December 2018. doi: 10.1136/bcr-2013-201778.
  • Elezovic I, Boskovic D, Tomin D, Pilic Z, Mikovic Z, Popovic M, Knezevic S, Sukalo M. Cesarean section combined with splenectomy in severely resistant immune thrombocytopenia. Acta Chir Iugosl 2002;49:51–54.
  • Varghese L, Viswabandya A, Mathew AJ. Dapsone, danazol, and intrapartum splenectomy in refractory ITP complicating pregnancy. Indian J Med Sci 2008;62:452–455.
  • Kojouri K, Vesely S, Deirda T, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic pupura: a systematic review to assess long-term platelet count response, prediction of response, and surgical complications. Blood 2004;104:2623–2634. doi: 10.1182/blood-2004-03-1168.
  • Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2009;9:29. doi: 10.1186/1471-2393-9-29.
  • Sentilhes L, Winer N, Azria E, Senat MV, Le Ray C, Vardon D, Perrotin F, Desbriere R, Fuchs F, Kayem G, et al. Tranexamic acid for the prevention of blood loss after vaginal delivery. N Engl J Med 2018;379:731–742. doi: 10.1056/NEJMoa1800942.
  • WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017;389:2105–2106. doi: 10.1016/S0140-6736(17)30638-4.
  • Chua SJ, Morton MR, Svigos J, Ross DM, Kane S. Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: two case reports with maternal and fetal outcomes and literature review. Obstet Med 2018. doi: 10.1177/1753495X18773960.
  • Alkaabi JK, Alkindi S, Al Riyami N, Zia F, Balla LMA, Balla SM. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus. Lupus 2012;21:1571–1574. doi: 10.1177/0961203312463621.
  • Patil AS, Dotters-Katz SK, Metjian AD, James AH, Swamy GK. Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy. Obstet Gynecol 2013;122:483–485. doi: 10.1097/AOG.0b013e31828d5b56.
  • Decroocq J, Marcellin L, Le Ray C, Willems L. Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. Obstet Gynecol 2014;124:481–483. doi: 10.1097/AOG.0000000000000371.
  • Kuter DJ, Bussel JB, Newland A, Baker RI, Lyons RM, Wasser J, Viallard JF, Macik G, Rummel M, Nie K, et al. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. Br J Haematol 2013;161:411–423. doi: 10.1111/bjh.12260.
  • Ferreira IJMCF, Sousa F, Vasco EM, Areia ALFA, Moura JPAS, Carda J, Ribeiro L. Severe immune thrombocytopenia in pregnancy treated with eltrombopag – a case report. J Gynecol Obstet Hum Reprod 2018;47:405–408. doi: 10.1016/j.jogoh.2018.06.010.
  • Favier R, De Carne C, Elefant E, Lapusneanu R, Gkalea V, Rigouzzo A. Eltrombopag to treat thrombocytopenia during last month of pregnancy in a woman with MYH9-related disease: a case report. A A Pract 2018;10:10–12.
  • Purushothaman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S. A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag. Asian J Transfus Sci 2016;10:155–158. doi: 10.4103/0973-6247.177204.
  • Suzuki N, Hiraga J, Hariyama Y, Takagi Y, Ohashi H, Kishigami Y, Oguchi H, Kagami Y. A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag. Int J Hematol 2018;108:109–111. doi: 10.1007/s12185-017-2383-1.
  • Veneri D, Franchini M, Raffaelli R, Musola M, Memmo A, Franchi M, Pizzolo G. Idiopathic thrombocytopenic purpura in pregnancy: analyses of 43 consecutive cases followed at a single Italian institution. Ann Hematol 2006;85:552–554. doi: 10.1007/s00277-006-0120-6.
  • Combs CA, Murphy EL, Laros JRK. Factors associated with postpartum haemorrhage with vaginal birth. Obstet Gynecol 1991;77:69–76.
  • Oyelese Y, Ananth CV. Postpartum haemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 1991;77:69–76.
  • RANZCOG: Management of postpartum haemorrhage. Sydney, NSW: The Royal Australian and New Zealand College of Obstetricians and Gynaecologists; 2017 July [cited 2019 Jan 30]; Available from: https://www.ranzcog.edu.au/
  • Begley CM, Gyte GML, Devane D, McGuire W, Weeks A, Biesty LM. Active versus expectant management in the third stage of labour. Cochrane Database Sys Rev 2019. doi: 10.1002/14651858.CD000007.
  • Fujimura K, Harada Y, Fujimoto T, Kuramoto A, Ikeda Y, Akatsuka J, Dan K, Omine M, Mizoguchi H. Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol 2002;75:426–433.
  • Sharon R, Tatarsky I. Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura. Am J Hematol 1994;46:87–90.
  • Payne SR, Resnik R, Moore TR, Hedriana HL, Kelly TF. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial haemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol 1997;177:149–155. doi: 10.1016/s0002-9378(97)70454-x.
  • Ekeus C, Hogberg U, Norman M. Vacuum assisted birth and risk for cerebral complication in term newborn infants: a population-based cohort study. BMC Pregnancy Childbirth 2014;14:36. doi: 10.1186/1471-2393-14-36.
  • NYSORA: Epidural anesthesia and analgesia. New York, USA: New York School of Regional Anesthesia; 2019 [cited 2019 Apr 2]; available from https://www.nysora.com/regional-anesthesia-for-specific-surgical-procedures/abdomen/epidural-anesthesia-analgesia/
  • Australian and New Zealand College of Anaesthetists Faculty of Pain Medicine. Guidelines for the management of major regional anaesthesia. 2014, PS03.
  • Lee LO, Bateman BT, Kheterpal S, Klumpner TT, Housey M, Aziz MF, Hand KW, MacEachern M, Goodier CG, Bernstein J, et al. Risk of epidural hematoma after neuraxial techniques in thrombocytopenic parturients: a report from the multicenter perioperative outcomes group. Anesthesiology 2017;126:1053–1063. doi: 10.1097/ALN.0000000000001630.
  • van Veen JJ, Nokes TJ, Makris M. The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals.Br J Haematol 2010;148(1):15–25. doi: 10.1111/j.1365-2141.2009.07899.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.